2-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]-1H-1,3-benzodiazole

Catalog No. :
ACNHWO261
CAS No. :
1393845-65-2
Molecular Formula :
C13H7ClF3N3
Molecular Weight :
297.67

IUPAC Name:2-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-1H-benzo[d]imidazole

2-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]-1H-1,3-benzodiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$109.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]-1H-1,3-benzodiazole
IUPAC Name2-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-1H-benzo[d]imidazole
MDL No.MFCD22383952
Molecular FormulaC13H7ClF3N3
Molecular Weight297.67
SMILESFC(C1=CN=C(C2=NC3=CC=CC=C3N2)C(Cl)=C1)(F)F
InChI KeyVUOIENCKNVPLDS-UHFFFAOYSA-N
Synonym2-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]-1H-1,3-benzodiazole;2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-1H-benzimidazole;1H-Benzimidazole, 2-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-
CAS No.1393845-65-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACNHWO261 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEYGA894 route compound structure diagram
    ACEYGA89480194-68-9 In Stock
  4. Then
  5. ACNHWO261 route product structure diagram
    ACNHWO2611393845-65-2
Inquiry

2. ACNHWO261 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTMQV917 route compound structure diagram
    ACTMQV91775806-84-7 In Stock
  4. Then
  5. ACNHWO261 route product structure diagram
    ACNHWO2611393845-65-2
Inquiry

Comments (0)